An Alzheimer’s patient may be able to have synaptic connections restored even with plaques and tangles already in his or her brain
The first experimental drug to boost brain synapses lost in Alzheimer’s disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called NitroMemantine, combines two FDA-approved medicines to stop the destructive cascade of changes in the brain that destroys the connections between neurons, leading to memory loss and cognitive decline.
The decade-long study, led by Stuart A. Lipton, M.D., Ph.D., professor and director of the Del E. Webb Center for Neuroscience, Aging, and Stem Cell Research, who is also a practicing clinical neurologist, shows that NitroMemantine can restore synapses, representing the connections between nerve cells (neurons) that have been lost during the progression of Alzheimer’s in the brain. The research findings are described in a paper published June 17 by the Proceedings of the National Academy of Sciences of the United States of America (PNAS).
The focus on a downstream target to treat Alzheimer’s, rather than on amyloid beta plaques and neurofibrillary tangles—approaches which have shown little success—“is very exciting because everyone is now looking for an earlier treatment of the disease,” Lipton said. “These findings actually mean that you might be able to intercede not only early but also a bit later.” And that means that an Alzheimer’s patient may be able to have synaptic connections restored even with plaques and tangles already in his or her brain.
Targeting lost synapses
In their study, conducted in animal models as well as brain cells derived from human stem cells, Lipton and his team mapped the pathway that leads to synaptic damage in Alzheimer’s. They found that amyloid beta peptides, which were once thought to injure synapses directly, actually induce the release of excessive amounts of the neurotransmitter glutamate from brain cells called astrocytes that are located adjacent to the nerve cells.
Normal levels of glutamate promote memory and learning, but excessive levels are harmful. In patients suffering from Alzheimer’s disease, excessive glutamate activates extrasynaptic receptors, designated eNMDA receptors (NMDA stands for N-methyl-D-aspartate), which get hyperactivated and in turn lead to synaptic loss.
The Latest Bing News on:
- Childhood Alzheimer’s: A Chester County boy and his family are seeking help against a burglar of innocence | Maria Panaritison January 25, 2021 at 2:26 pm
Two years ago, an elementary school psychologist told Marisa DiChiacchio something that she describes, to this day, as “crazy.” Marisa’s 9-year-old son, Connor, was, quite literally, losing his mind.
- First observation of the early association between proteins linked to Alzheimer's diseaseon January 25, 2021 at 10:19 am
During the pre-clinical stages of Alzheimer's disease, i.e. when subtle changes are taking place in the brain but no cognitive symptoms can be observed, the cortex presents a state of transient ...
- Alzheimer's Assoc. of Greater Cincinnati with resources to help during the pandemicon January 25, 2021 at 10:12 am
Alzheimer's Assoc. of Greater Cincinnati with resources to help during the pandemic ...
- Alzheimer’s Foundation offering college scholarship to high school seniorson January 25, 2021 at 9:50 am
The Alzheimer’ (AFA) is offering scholarships to college-bound high school seniors affected by Alzheimer’s disease of up to $5,000 as part of its annual Teens for Alzheimer’s ...
- Those with Alzheimer's, dementia struggling with pandemic isolationon January 25, 2021 at 9:37 am
People living with Alzeheimer's or dementia are finding the pandemic is placing an increased burden on their lives. Isolation brought on by the lack of social interaction is one of the causes.
- First observation of the early link between proteins linked to Alzheimer's diseaseon January 25, 2021 at 8:22 am
Study conducted by researchers from the GIGA CRC In vivo Imaging laboratory at ULiège demonstrates, for the first time in humans, how the first deposits of tau proteins in the brainstem are associated ...
- Alector Announces First Participant Dosed in Phase 2 Study Evaluating AL002 in Individuals with Early Alzheimer’s Diseaseon January 25, 2021 at 5:53 am
AL002 is the first product candidate targeting TREM2 in Phase 2 clinical developmentStudy will enroll early Alzheimer’s disease patients at up to ...
- Alzheimer’s Association offers virtual educational programson January 25, 2021 at 5:44 am
The Alzheimer’s Association Northwest Ohio Chapter will be presenting a variety of virtual educational programs to help the community and families impacted by the disease.
- The Alzheimer's Drugs Showing Early Promiseon January 22, 2021 at 3:08 pm
A small study has found that the experimental drug donanemab may slow cognitive decline in Alzheimer's patients. It joins others that show promise.
- Outreach is key when it comes to the Black community and Alzheimer'son January 22, 2021 at 11:43 am
According to the Alzheimer’s Prevention Initiative, Black people are more than twice as likely as white people to develop Alzheimer’s disease.
The Latest Google Headlines on:
The Latest Bing News on:
- Neuronal Adhesion and Synapse Organization in Recovery After Brain Injuryon January 19, 2021 at 4:00 pm
whether tissues undergo remodeling and to what extent synapse-organizing adhesion and signaling proteins contribute to the restoration of neuronal connectivity in later stages.
- How to reroute a broken neural circuiton January 19, 2021 at 8:17 am
Upadhyaya, Rabinowitch and Bai also discovered that the synthetic synapses can restore odor-sensing behavior in worms with damaged AIA neurons even when neural information flow continues along its ...
- Learning and Memory in the Brain: How Science Cracked Your Mind's Codeon January 17, 2021 at 4:00 pm
He went on to determine the biochemical changes that accompany memory formation, showing that short-term memory involves a functional modulation of the synapses while long-term memory requires the ...
- Now, a cure for dumbnesson January 12, 2021 at 10:59 pm
Roderick McInnes of Toronto University and Michael Salter of the Sick Kids hospital here have discovered that the protein called Neto1 can restore memory ... key component of synapses - the ...
- Trisomy 21–induced dysregulation of microglial homeostasis in Alzheimer’s brains is mediated by USP25on January 3, 2021 at 8:14 pm
Mechanistically, USP25 deficiency attenuates microglia-mediated proinflammatory cytokine overproduction and synapse elimination. Inhibition of USP25 reestablishes homeostatic microglial signatures and ...
- Synapse XT Review – Does Synapse XT Pills Truly Work?on December 26, 2020 at 9:44 am
Synapse XT capsules can be used by those who would like to take natural remedies for their tinnitus symptoms. The supplement provides a soothing and stimulating way to enhance and restore the quality ...
- Astrocytes Eat Neuronal Connections to Maintain Plasticity in Adult Brains: Studyon December 26, 2020 at 3:30 am
‘Changes in synapse number have strong association with ... "It is intriguing to postulate that modulating astrocytic phagocytosis to restore synaptic connectivity may be a novel strategy ...
- Researchers find mechanism underlying plasticity in adult brainson December 24, 2020 at 3:33 pm
Changes in synapse number have a strong association ... "It is intriguing to postulate that modulating astrocytic phagocytosis to restore synaptic connectivity may be a novel strategy in treating ...
- Astrocytes eat connections to maintain plasticity in adult brainson December 23, 2020 at 3:59 pm
"Changes in synapse number have strong association with ... "It is intriguing to postulate that modulating astrocytic phagocytosis to restore synaptic connectivity may be a novel strategy in ...
- Technology Insight: Future Neuroprosthetic Therapies for Disorders of the Nervous Systemon December 15, 2020 at 4:00 pm
The neuroprosthetic approach to restoring these lost functions is based ... require the activation of hundreds of thousands of synapses between thousands of sensory and motor neurons.